NEGATIVE INOTROPIC EFFECTS OF PLATELET ACTIVATING FACTOR INVIVO

被引：0
|
作者：
KENZORA, JL [1 ]
PEREZ, JE [1 ]
BERGMANN, SR [1 ]
LANGE, LG [1 ]
机构：
[1] WASHINGTON UNIV,DIV CARDIOVASC,ST LOUIS,MO 63130
来源：
CLINICAL RESEARCH | 1983年 / 31卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A195 / A195
页数：1
相关论文
共 50 条
  • [21] Effects of lignocaine on platelet activating factor production
    Sridhar, K.
    Murphy, D.
    Shorten, G.
    EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2004, 21 : 55 - 55
  • [22] CARDIOVASCULAR EFFECTS OF PLATELET-ACTIVATING-FACTOR
    HOLLAND, MR
    MCINTYRE, TM
    ZIMMERMAN, GA
    PRESCOTT, SM
    TRENDS IN CARDIOVASCULAR MEDICINE, 1991, 1 (03) : 117 - 121
  • [23] CARDIOVASCULAR EFFECTS OF PLATELET-ACTIVATING-FACTOR
    GOLDSTEIN, RE
    FEUERSTEIN, GZ
    BRADLEY, LM
    STAMBOULY, JJ
    LAURINDO, FRM
    DAVENPORT, NJ
    LIPIDS, 1991, 26 (12) : 1250 - 1256
  • [24] EFFECTS OF PLATELET-ACTIVATING-FACTOR RECEPTOR ANTAGONISTS ON INTRACELLULAR PLATELET-ACTIVATING-FACTOR FUNCTION IN NEUTROPHILS
    KOIKE, H
    IMANISHI, N
    NATSUME, Y
    MOROOKA, S
    EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1994, 269 (03): : 299 - 309
  • [25] PRIMING INTERACTIONS BETWEEN PLATELET-ACTIVATING-FACTOR AND HISTAMINE IN THE INVIVO MICROCIRCULATION
    TOMEO, AC
    EGAN, RW
    DURAN, WN
    FASEB JOURNAL, 1991, 5 (13): : 2850 - 2855
  • [26] TRIAZOLODIAZEPINES ARE POTENT ANTAGONISTS OF PLATELET-ACTIVATING-FACTOR (PAF) INVITRO AND INVIVO
    CASALSSTENZEL, J
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1987, 335 (03) : 351 - 355
  • [27] THE INVIVO AND INVITRO RENAL HEMODYNAMIC-RESPONSE TO PLATELET ACTIVATING FACTOR (PAF)
    SCHIRMER, WJ
    GALAT, JA
    SCHIRMER, JM
    ROBINSON, AV
    RHODES, RS
    FRY, DE
    CIRCULATORY SHOCK, 1988, 24 (04) : 253 - 254
  • [28] PLATELET ACTIVATING FACTOR (PAF) ATTENUATES BETA-ADRENOCEPTOR-MEDIATED INOTROPIC RESPONSES IN THE RAT
    VANMEEL, JCA
    MAUZ, ABM
    WIENEN, W
    DIEDEREN, W
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 183 (02) : 354 - 355
  • [29] INTERFERENCE OF SULFYNPYRAZONE WITH THE PLATELET AND BRONCHIAL EFFECTS OF PLATELET-ACTIVATING FACTOR
    VARGAFTIG, BB
    LEFORT, J
    WAL, F
    CHIGNARD, M
    THROMBOSIS AND HAEMOSTASIS, 1981, 46 (01) : 270 - 270
  • [30] INVITRO AND INVIVO EFFECTS OF SM-10661, A NEWLY SYNTHESIZED PLATELET-ACTIVATING FACTOR(PAF) ANTAGONIST
    MOROOKA, S
    KOMURO, Y
    ANDO, R
    UCHIDA, M
    PROSTAGLANDINS, 1988, 35 (05): : 840 - 840
12345